NASDAQ · Medical - Devices

SGHT (SGHT) Stock

$5.12 +4.28% NASDAQ: SGHT Healthcare

Valuation

MetricValue
Price$5.12
Market Cap$278.58M
P/E Ratio-6.32
P/B Ratio3.98
P/S Ratio3.32
EPS (TTM)$-0.74
52-Week High$9.24
52-Week Low$3.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-59.37%
ROA-33.04%
ROCE-57.81%
Gross Margin-48.05%
Operating Margin-48.05%
Net Margin-46.83%
Debt/Equity0.76
Current Ratio10.27

Annual Financials (USD)

Metric20212022202320242025
Revenue$49.0M$71.0M$81.0M$80.0M$77.0M
Operating Profit$-51.0M$-84.0M$-57.0M$-51.0M$-37.0M
Net Profit$-63.0M$-86.0M$-56.0M$-52.0M$-38.0M
EPS$-1.33$-1.80$-1.14$-1.03$-0.74
Op Margin-105.2%-117.7%-70.7%-63.3%-48.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$280.0M$213.0M$167.0M$143.0M$115.0M
Total Liabilities$48.0M$53.0M$46.0M$55.0M$51.0M
Cash$261.0M$185.0M$138.0M$120.0M$92.0M
Borrowings$34.0M$35.0M$35.0M$40.0M$41.0M

Latest News

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 22, 2026 Discover 3 Promising Penny Stocks With Market Caps Over $20M Simply Wall St. · Jun 9, 2026 Sight Sciences Q1 Earnings Call Highlights MarketBeat · May 7, 2026 Sight Sciences, Inc. Q1 2026 Earnings Call Summary Moby · May 7, 2026 Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates Zacks · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-53.0M$-76.0M$-47.0M$-22.0M$-30.0M
Investing Cash Flow$-2.0M$-2.0M$-2.0M$-1.0M$0
Financing Cash Flow$-4.0M$0$0$0$0
Net Cash Flow$199.0M$-76.0M$-47.0M$-18.0M$-28.0M
Free Cash Flow$-53.0M$-77.0M$-48.0M$-23.0M$-30.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-9.61%
Quick Ratio5.48
Interest Coverage-7.40
Return 1Y24.34%
Return 3Y-42.96%
Return 5Y-84.93%

Ownership

Insiders Held19.98%
Institutions Held53.59%
Institutions Float Held66.98%
Institutional HolderSharesReport Date
KCK LTD.4,374,9752025-09-30
Long Focus Capital Management, LLC3,594,1002026-03-31
Blackrock Inc.2,831,9322026-03-31
Pathstone Holdings, LLC2,397,3322026-03-31
Americana Partners, LLC1,679,0172026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CERS $2.32 +2.20% -34.25 $467.54M 0.00%
CVRX $4.88 +2.95% -2.98 $129.50M 0.00%
LFCR $4.34 +0.23% -3.77 $162.79M 0.00%
MASS $8.30 -1.31% 12.81 $340.53M 0.00%
OMIOwens & Minor, Inc. $2.68 +8.94% 14.39 $207.07M 0.00%

About SGHT

SGHT is led by CEO Paul Badawi, employs 216 people, headquartered in US, publicly traded since 2021.

SGHT stock trades at $5.12 with a market capitalization of $278.58M. The stock is valued at a price-to-earnings (P/E) ratio of -6.32, price-to-book of 3.98, price-to-sales of 3.32. Over the past 52 weeks the stock has ranged between $3.11 and $9.24, and currently trades 44.6% below its 52-week high.

On profitability, SGHT generates a return on equity (ROE) of -59.37%, return on capital employed of -57.81%, an operating margin of -48.05%, a net profit margin of -46.83%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides